Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer

Author： Taeb J.   Artru P.   Baujat B.   Mabro M.   Carola E.   Maindrault F.   Tournigand C.   Krulik M.   Louvet C.   de Gramont A.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.38, Iss.5, 2002-03, pp. : 661-666

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Study of Continuous Infusion 5-Fluorouracil (5-FU) with Epirubicin and Cisplatin in Metastatic, Hormone-resistant Prostate Cancer: an Active New Regimen

By Chao D.   von Schlippe M.   Harland S.J.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1230-1233

Elsevier

Access to resources Recommend Favorite

Randomised Phase II Study of Cisplatin and 5-Fluorouracil (5-FU) Versus Cisplatin Alone in Advanced Squamous Cell Oesophageal Cancer

By Bleiberg H.   Conroy T.   Paillot B.   Lacave A.J.   Blijham G.   Jacob J.H.   Bedenne L.   Namer M.   De Besi P.   Gay F.   Collette L.   Sahmoud T.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1216-1220

Elsevier

Access to resources Recommend Favorite

Clinical Benefit with Cisplatin, Hydroxyurea and 5-Fluorouracil/Leucovorin in Advanced Pancreatic Adenocarcinoma

By Raymond E.   de Gramont A.   Louvet C.   Tournigand C.   Demuynck B.   Beerblock K.   Carola E.   Krulik M.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 696-697

Elsevier

Access to resources Recommend Favorite

Epirubicin, Cisplatin and Infusional 5-Fluorouracil (5-FU) (ECF) in Hepatobiliary Tumours

By Ellis P.A.   Norman A.   Hill A.   O'Brien M.E.R.   Nicolson M.   Hickish T.   Cunningham D.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1594-1598

Elsevier

Access to resources Recommend Favorite

Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study

By Catalano Vincenzo   Vincenzi Bruno   Giordani Paolo   Graziano Francesco   Santini Daniele   Baldelli Anna   Alessandroni Paolo   Schiavon Gaia   Rossi David   Casadei Virginia   D’Emidio Silvia   Luzi Fedeli Stefano   Tonini Giuseppe   Fiorentini Giammaria  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 419-426

Springer Publishing Company

Access to resources Recommend Favorite